About AVITA Medical, Inc.
https://www.avitamedical.comAVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo.
CEO
James M. Corbett
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-06-30 | Reverse | 1:5 |
| 2017-10-17 | Forward | 1121:1000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 49
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.78M
Value:$6.17M
VANGUARD GROUP INC
Shares:1.37M
Value:$4.72M
BLACKROCK, INC.
Shares:1.14M
Value:$3.94M
Summary
Showing Top 3 of 87
About AVITA Medical, Inc.
https://www.avitamedical.comAVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $17.06M ▼ | $23.03M ▼ | $-13.19M ▼ | -77.29% ▼ | $-0.46 ▼ | $-11.33M ▼ |
| Q2-2025 | $18.42M ▼ | $26.1M ▼ | $-9.92M ▲ | -53.86% ▲ | $-0.38 ▲ | $-8.11M ▲ |
| Q1-2025 | $18.51M ▲ | $27.51M ▲ | $-13.86M ▼ | -74.86% ▼ | $-0.53 ▼ | $-12.1M ▼ |
| Q4-2024 | $18.41M ▼ | $26.08M ▼ | $-11.59M ▲ | -62.96% ▲ | $-0.44 ▲ | $-9.86M ▲ |
| Q3-2024 | $19.55M | $30.16M | $-16.2M | -82.91% | $-0.62 | $-14.56M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $23.31M ▲ | $63.73M ▲ | $70.39M ▼ | $-6.67M ▲ |
| Q2-2025 | $15.69M ▼ | $58.13M ▼ | $71.03M ▼ | $-12.89M ▼ |
| Q1-2025 | $25.82M ▼ | $69.56M ▼ | $74.13M ▼ | $-4.57M ▼ |
| Q4-2024 | $35.88M ▼ | $79.71M ▼ | $75.21M ▲ | $4.5M ▼ |
| Q3-2024 | $44.41M | $81.05M | $68.82M | $12.23M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-13.19M ▼ | $-5.22M ▲ | $-5.34M ▼ | $13.77M ▲ | $3.21M ▲ | $-6.17M ▲ |
| Q2-2025 | $-9.92M ▲ | $-10.23M ▲ | $7.02M ▼ | $559K ▲ | $-2.65M ▼ | $-10.75M ▼ |
| Q1-2025 | $-13.86M ▼ | $-10.31M ▼ | $10.77M ▲ | $363K ▼ | $820K ▲ | $-10.54M ▼ |
| Q4-2024 | $-11.59M ▲ | $-8.08M ▼ | $2.47M ▼ | $1.02M ▲ | $-4.59M ▼ | $-9.71M ▲ |
| Q3-2024 | $-16.2M | $-7.21M | $7.39M | $1.01M | $1.19M | $-11.03M |
Revenue by Products
| Product | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 Lease Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Recell System | $0 ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 AUSTRALIA | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 European Union | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 JAPAN | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
CEO
James M. Corbett
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-06-30 | Reverse | 1:5 |
| 2017-10-17 | Forward | 1121:1000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 49
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.78M
Value:$6.17M
VANGUARD GROUP INC
Shares:1.37M
Value:$4.72M
BLACKROCK, INC.
Shares:1.14M
Value:$3.94M
Summary
Showing Top 3 of 87